Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
09/2012
09/13/2012US20120230980 OPTIMIZED Fc VARIANTS AND METHODS FOR THEIR GENERATION
09/13/2012US20120230959 Enhancement of placental stem cell potency using modulatory rna molecules
09/13/2012US20120230955 Arabinoxylans for modulating the barrier function of the intestinal surface
09/13/2012US20120230953 Methods and compositions for immunotherapy and detection of inflammatory and immune-dysregulatory disease, infectious disease, pathologic angiogenesis and cancer
09/13/2012US20120230951 Antiviral compounds
09/13/2012US20120230947 Biologically active proteins having increased in vivo and/or in vitro stability
09/13/2012US20120230946 Fusion molecules and il-15 variants
09/13/2012US20120230945 Targeted particles and methods of using the same
09/13/2012US20120230911 Tnf-alpha binding proteins
09/12/2012EP2497829A1 Super-agonistic anti-CD-28 antibodies
09/12/2012EP2497498A1 Therapeutic agent for autoimmune diseases or allergy, and method for screening for the therapeutic agent
09/12/2012EP2497496A2 Methods for the treatment of autoimmune disorders using immunosuppressive monoclonal antibodies with reduced toxicity
09/12/2012EP2497469A1 Use of danshensu, notoginsenoside r1 or their combination in preparation of medicaments for preventing and treating diseases caused by microcirculation disorder
09/12/2012EP2496576A1 Imidazo [4, 5-c]quinoline derivates as bromodomain inhibitors
09/12/2012EP2496568A1 Polymorph of 3-(substituteddihydroisoindolinone-2-yl)-2,6-dioxopiperidine, and pharmaceutical compositions thereof
09/12/2012EP2496567A2 Novel benzopyran kinase modulators
09/12/2012EP2496558A1 Thetrahydroquinolines derivatives as bromodomain inhibitors
09/12/2012EP2496544A1 Gpbp inhibition using q2 peptidomimetics
09/12/2012CN102666545A Heterocyclyl pyrazolopyrimidine analogues as jak inhibitors
09/12/2012CN102666542A Pyrazolopyrimidine derivatives
09/12/2012CN102666508A Phenyloxadiazole derivatives as pgds inhibitors
09/12/2012CN102666500A Seven-membered ring compound and pharmaceutical use therefor
09/12/2012CN102665759A Humanized antibodies against human il-22ra
09/12/2012CN102665706A Antioxidant composition
09/12/2012CN102665703A Inhibitors of CXCR1/2 as adjuvants in the transplant of pancreatic islets
09/12/2012CN102665428A Infant formula with probiotics and milk fat globule membrane components
09/12/2012CN102660569A Method for preparing recombinant human IgE receptor protein and application of recombinant human IgE receptor protein
09/12/2012CN102660499A Placental hematopoietic stem cell and preparation method thereof and placental hematopoietic stem cell injection
09/12/2012CN102660419A Multifunctional health-care wine
09/12/2012CN102659958A Dandelion polysaccharide extract and preparation method and application thereof
09/12/2012CN102659945A Anti-C5aR antibodies and uses thereof
09/12/2012CN102659944A IL-18 binding proteins
09/12/2012CN102659941A Binding molecules
09/12/2012CN102659940A 结合分子 Binding molecules
09/12/2012CN102659931A Immunoenhancer and preparation method
09/12/2012CN102659876A Flavonoid glycoside extracted from cardamine tangutorum and preparation method thereof
09/12/2012CN102659705A Synthetic method of 3,4-disubstituted isoxazole compound
09/12/2012CN102657877A Examination and monitoring method of immunological recurrent spontaneous abortion
09/12/2012CN102657876A Drug treatment and monitoring method of immunological recurrent spontaneous abortion
09/12/2012CN102657863A Method for preparing and storing low temperature particles for active medicament
09/12/2012CN102657791A Chinese medicinal composition containing pale butterflybush flower and preparation method thereof
09/12/2012CN102657708A Anti-influenza medicine with immune regulating function and preparation method thereof
09/12/2012CN102657693A SH2-containing tyrosine phosphatase 1(SHP-1) inhibitor and preparation thereof
09/12/2012CN102657683A Preparation method of immune toxoid
09/12/2012CN102657659A Transdermally-absorbed medicament used for skin and consisting of adjuvant-containing fluticasone propionate and adjuvant-containing water
09/12/2012CN102657656A Composition and methods for modulating a kinase cascade
09/12/2012CN102657651A Inhibition of inflammation using alpha 7 receptor-binding cholinergic agonists
09/12/2012CN102657643A Composite organic acid-calcium effervescent tablet and preparation method thereof
09/12/2012CN102657260A Antiallergic lactobacillus
09/12/2012CN102268098B Method for preparing yerbadetajo herb polyferose complex and application thereof
09/12/2012CN102232957B Use of 3-acetoxyl-8, 24-lanostadiene-21-acid in preparing medicines for preventing or treating liver cancer or breast cancer
09/12/2012CN102228576B Chinese patent medicine for treating discoid lupus erythematosus
09/12/2012CN102205067B Traditional Chinese medicine composition for treating chronic urticaria
09/12/2012CN102188684B Chinese medicinal acupoint application plaster for treating allergic rhinitis and preparation method thereof
09/12/2012CN102188660B Chinese medicinal health-care medicinal liquor
09/12/2012CN102178647B Pranlukast injection preparation
09/12/2012CN102145136B Chinese medical meridian physiotherapy liquid and preparation method and application thereof
09/12/2012CN102048682B Loratadine cream and application thereof
09/12/2012CN101874627B Pearl powder health-care food for enhancing immunity
09/12/2012CN101781347B Polymorphic substances of decitabine and medical compositions
09/12/2012CN101760446B Method for preparing monocyte type stem cell and application
09/12/2012CN101583598B Novel indole derivative having inhibitory activity on i kappa b kinase
09/12/2012CN101368152B Preparation method for cordyceps sinensis solid haelth-care medicinal wine
09/11/2012US8263756 Injecting aqueous solution containing an expression vector comprising desired gene; gene therapy wherein hepatocyte growth factor (HGF) gene is introduced by electroporation into kidney to be transplanted
09/11/2012US8263637 Methods for treatment of multiple myeloma using cyclopropane carboxylic acid {2-[(is)-1-(3-ethoxy-4-methoxy-phenyl)-2-methanesulfonyl-ethyl]-3-oxo-2,3-dihydro-1 h-isoindol-4-yl}-amide
09/11/2012US8263597 Indazole compounds as CCR1 receptor antagonists
09/11/2012US8263590 Pyrimidine derivatives
09/11/2012US8263559 Feline granulocyte macrophage colony stimulating factor proteins
09/11/2012US8263394 Polynucleotides encoding antigenic HIV type B polypeptides, polypeptides, and uses thereof
09/11/2012US8263346 Nonhuman model animal lacking the ability to control lymphocyte migration
09/11/2012US8263326 Compounds and methods for modulating activation of NF-κB
09/11/2012US8263089 Compounds and methods for treatment and diagnosis of chlamydial infection
09/11/2012US8263082 Chemically programmable immunity
09/11/2012US8263070 Using immunoglobulin specific to receptor for OX-2 membrane glycoprotein as diagnostic and therapeutic tool for treatment and prevention of asthma, infection, allergies, skin and cell proliferative disorders
09/11/2012CA2635352C Stabilized antibody formulation
09/11/2012CA2544920C Method for the treatment of multiple sclerosis by inhibiting il-17 activity
09/11/2012CA2474402C Prophylactic and therapeutic treatment of infectious and other diseases with immunoeffector compounds
09/11/2012CA2395291C Five-helix protein
09/11/2012CA2326407C Retroviral vectors including modified envelope escort proteins
09/07/2012WO2012119056A1 Proteasome inhibitor delanzomib for use in the treatment of lupus
09/07/2012WO2012118863A1 Therapies that target autoimmunity for treating glaucoma and optic neuropathy
09/07/2012WO2012118857A2 Immunologically modified carbon nanotubes for cancer treatment
09/07/2012WO2012118154A1 Novel vitamin d receptor modulator with partial agonist activity
09/07/2012WO2012118124A1 Novel chemokine receptor antagonist
09/07/2012WO2012117855A1 (nucleic acid)-polysaccharide complex
09/07/2012WO2012117532A1 Cancer inhibiting agent, antibody production enhancing agent, and therapeutic agent for hepatitis
09/07/2012WO2012117219A1 Pyrrolidine derivatives as selective glycosidase inhibitors and uses thereof
09/07/2012WO2012117067A1 Antagonistic dr3 ligands
09/07/2012WO2012117062A1 Piperidinyl benzoimidazole derivatives as mpges-1 inihibitors
09/07/2012WO2012116666A1 Pyrimidine compounds inhibiting the formation of nitric oxide and prostaglandin e2, method of production thereof and use thereof
09/07/2012WO2012116586A1 2-aminothiazole derivative, preparation method, and use
09/07/2012WO2012116585A1 Pharmaceutical use of aminothiazole myd88 specificity inhibitor
09/07/2012WO2012062900A3 Frozen confections containing probiotic micro-organisms
09/07/2012CA2828801A1 2-aminothiazole derivative, preparation method, and use
09/07/2012CA2828796A1 Pharmaceutical use of aminothiazole myd88 specificity inhibitor
09/07/2012CA2828464A1 Antagonistic dr3 ligands
09/07/2012CA2827859A1 Biological markers and methods for predicting response to b-cell antagonists
09/07/2012CA2827653A1 Proteasome inhibitor delanzomib for use in the treatment of lupus
09/06/2012US20120225955 Detection of autoantibodies reactive with pancreatic islet cell antigenic molecules and/or insulin
09/06/2012US20120225945 Compositions comprising a fatty acid oil mixture and a surfactant, and methods and uses thereof